HK Biotech Firm Gears up for IPO with $12m Funding

Immuno Cure: HK Biotech Firm Gears up for IPO with $12m Funding

Immuno Cure focuses on R&D of immunotherapies for cancers, inflammatory and infectious diseases As part of its US$27 million series A round, Immuno Cure has raised US$12 million. The AEF Greater Bay Area Fund, which is run by Gobi Partners GBA, was in charge of getting the money. The Hong Kong Science Park-based biotech company […]

Immuno Cure: HK Biotech Firm Gears up for IPO with $12m Funding Read More ยป